Welcome to LookChem.com Sign In|Join Free

CAS

  • or

14937-74-7

Post Buying Request

14937-74-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

14937-74-7 Usage

Properties

Organic compound
Purine base structure
Contains a furan ring
Contains an amino group
Chemical formula: C11H10N4O2

Specific content

Potential pharmaceutical applications
Used as a building block in the synthesis of pharmaceutical drugs
Studied for potential as an anti-cancer and anti-viral agent
May have other biological activities
Potential for further research in drug development

Check Digit Verification of cas no

The CAS Registry Mumber 14937-74-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,9,3 and 7 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 14937-74:
(7*1)+(6*4)+(5*9)+(4*3)+(3*7)+(2*7)+(1*4)=127
127 % 10 = 7
So 14937-74-7 is a valid CAS Registry Number.

14937-74-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-amino-9-(furan-2-ylmethyl)-3H-purin-6-one

1.2 Other means of identification

Product number -
Other names 2-amino-9-furfuryl-1,9-dihydro-purin-6-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:14937-74-7 SDS

14937-74-7Upstream product

14937-74-7Downstream Products

14937-74-7Relevant articles and documents

Purine derivatives

-

, (2008/06/13)

Novel purine derivatives, particularly novel guanines and hypoxanthines, are described as agents for treating autoimmune diseases. Also novel methods of manufacture for the derivatives, pharmaceutical compositions thereof, and methods of use therefor are the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14937-74-7